Mitra Pedagang Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mitra Pedagang Indonesia Tbk. trades at Rp127 (market cap 184.38B, 62.37M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mitra Pedagang Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| MPIX | SCPI | |
|---|---|---|
Market Cap | 184.38B | 104.4B |
Volume | 62.37M | — |
Lot | 623.69K | — |
Turnover | 7.9B | — |
Average Price | 126.63 | — |
Value | 7.9B | — |
Indicative Equilibrium Price | 127 | — |
Indicative Equilibrium Volume | 11.69K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Mitra Pedagang Indonesia Tbk (theCompany) was established based on Deed No.2 dated July,2019 made before Notary Ika Anggraini,S.H.,M.Kn.in Malang. The Company started its commercial activities since 2019, by operating under the trademarks of MPStore. The Controlling Shareholder and Beneficial Owner of the Company is Abdul Muidz, through PT Madura Prima Investama, with direct ownership of the Company's shares.
Read more on MPIX →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →